Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trialsHiddo J.L. Heerspink, Ron T. Gansevoort, Josef Coresh et al.|The Lancet Diabetes & Endocrinology|2019Cited by 372
Intrarenal and Urinary Glycogen Synthase Kinase-3 Beta Levels in Diabetic and Nondiabetic Chronic Kidney DiseaseLingfeng Zeng, Cheuk‐Chun Szeto|Kidney & Blood Pressure Research|2023Cited by 4